146 related articles for article (PubMed ID: 30152048)
1. Diagnostic value of combination serum assay of lactate dehydrogenase, D-dimer, and C-reactive protein for uterine leiomyosarcoma.
Nishigaya Y; Kobayashi Y; Matsuzawa Y; Hasegawa K; Fukasawa I; Watanabe Y; Tokunaga H; Yaegashi N; Iwashita M
J Obstet Gynaecol Res; 2019 Jan; 45(1):189-194. PubMed ID: 30152048
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus.
Goto A; Takeuchi S; Sugimura K; Maruo T
Int J Gynecol Cancer; 2002; 12(4):354-61. PubMed ID: 12144683
[TBL] [Abstract][Full Text] [Related]
3. Leiomyosarcoma of the uterus: ultrasonography and serum lactate dehydrogenase level.
Seki K; Hoshihara T; Nagata I
Gynecol Obstet Invest; 1992; 33(2):114-8. PubMed ID: 1559623
[TBL] [Abstract][Full Text] [Related]
4. Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid.
Zhang G; Yu X; Zhu L; Fan Q; Shi H; Lang J
BMC Cancer; 2020 Jun; 20(1):514. PubMed ID: 32493236
[TBL] [Abstract][Full Text] [Related]
5. A more accurate method to interpret lactate dehydrogenase (LDH) isoenzymes' results in patients with uterine masses.
Di Cello A; Borelli M; Marra ML; Franzon M; D'Alessandro P; Di Carlo C; Venturella R; Zullo F
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():143-147. PubMed ID: 30925450
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison.
Kim HS; Han KH; Chung HH; Kim JW; Park NH; Song YS; Kang SB
Eur J Surg Oncol; 2010 Jul; 36(7):691-8. PubMed ID: 20570475
[TBL] [Abstract][Full Text] [Related]
7. Potential role of preoperative serum CA125 for the differential diagnosis between uterine leiomyoma and uterine leiomyosarcoma.
Juang CM; Yen MS; Horng HC; Twu NF; Yu HC; Hsu WL
Eur J Gynaecol Oncol; 2006; 27(4):370-4. PubMed ID: 17009628
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic value of lactate dehydrogenase-A and -D subunits in human uterine myoma and uterine sarcoma.
Song KJ; Yu XN; Lv T; Chen YL; Diao YC; Liu SL; Wang YK; Yao Q
Medicine (Baltimore); 2018 Apr; 97(14):e0268. PubMed ID: 29620641
[TBL] [Abstract][Full Text] [Related]
9. Serum microRNA profile enables preoperative diagnosis of uterine leiomyosarcoma.
Yokoi A; Matsuzaki J; Yamamoto Y; Tate K; Yoneoka Y; Shimizu H; Uehara T; Ishikawa M; Takizawa S; Aoki Y; Kato K; Kato T; Ochiya T
Cancer Sci; 2019 Dec; 110(12):3718-3726. PubMed ID: 31599471
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of CD44 standard and E-cadherin in atypical leiomyoma and leiomyosarcoma of the uterus.
Kaygusuz EI
J Obstet Gynaecol; 2015 Apr; 35(3):279-82. PubMed ID: 25140670
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma.
Sato K; Yuasa N; Fujita M; Fukushima Y
Am J Obstet Gynecol; 2014 Apr; 210(4):368.e1-368.e8. PubMed ID: 24368137
[TBL] [Abstract][Full Text] [Related]
12. MVP immunohistochemistry is a useful adjunct in distinguishing leiomyosarcoma from leiomyoma and leiomyoma with bizarre nuclei.
Lintel NJ; Luebker SA; Lele SM; Koepsell SA
Hum Pathol; 2018 Mar; 73():122-127. PubMed ID: 29307622
[TBL] [Abstract][Full Text] [Related]
13. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis between uterine sarcoma and leiomyoma using preoperative clinical characteristics.
Cho HY; Kim K; Kim YB; No JH
J Obstet Gynaecol Res; 2016 Mar; 42(3):313-8. PubMed ID: 26695124
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of D-Dimer Combined with WBC Count, Neutrophil Percentage and CRP in Differentiating Between Simple and.
Bu X; Chen J; Wan Y; Xu L
Clin Lab; 2016 Sep; 62(9):1675-1681. PubMed ID: 28164589
[TBL] [Abstract][Full Text] [Related]
17. Role of C-reactive protein, D-dimer, and fibrinogen levels in the differential diagnosis of central and peripheral vertigo.
Akinci E; Aygencel G; Keles A; Demircan A; Bildik F
Adv Ther; 2007; 24(5):1068-77. PubMed ID: 18029334
[TBL] [Abstract][Full Text] [Related]
18. The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.
Schwameis R; Grimm C; Petru E; Natter C; Staudigl C; Lamm W; Koelbl H; Krainer M; Brodowicz T; Reinthaller A; Polterauer S
PLoS One; 2015; 10(8):e0133838. PubMed ID: 26248232
[TBL] [Abstract][Full Text] [Related]
19. D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress.
Desch A; Gebhardt C; Utikal J; Schneider SW
Int J Cancer; 2017 Feb; 140(4):914-921. PubMed ID: 27813063
[TBL] [Abstract][Full Text] [Related]
20. Potential diagnostic biomarkers: differential expression of LMP2/β1i and cyclin B1 in human uterine leiomyosarcoma.
Hayashi T; Horiuchi A; Sano K; Hiraoka N; Ichimura T; Sudo T; Ishiko O; Yaegashi N; Aburatani H; Konishi I
Tumori; 2014; 100(4):99e-106e. PubMed ID: 25296613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
